SlideShare a Scribd company logo
ANJU.K.V.
MSC RADIATION PHYSICS
CALICUT UNIVERSITY
INTRODUCTION
With the introduction of miniaturized brachytherapy sources, the
sophisticated 3-D source localization methods have been
introduced, which can be linked to computerized methods for dose
calculation.
Therefore, a common language is valuable to provide a method of
dose specification and reporting which can be used for implants of
all types of interstitial brachytherapy procedures.
1985: ICRU Report 38,
Was written regarding the Dose and volume specification as
well as reporting intracavitary Brachytherapy in GYN.
1997: ICRU Report 58,
Was written to generate a guideline about the dose and
volumes specification for reporting interstitial Brachytherapy.
ICRU 58
Aim: to develop a common language based on existing Concepts.
1. usable to describe what has been done.
2. closely related to the outcome of the treatment.
3. generally understood.
Consistency with external beam radiotherapy (EBT)
definition of volumes – the same.
ICRU reference point for dosimetry in EBT – cannot be
taken over directly for interstitial BT.
ICRU 58
There are several historic systems of prescribing brachytherapy
• –Manchester system
• –Paris system
• Quimby system
• The term “system” denotes a set of rules which takes into account the
source types , strengths, geometry and method of application to
obtain suitable dose distributions over the volume(s) to be treated.
The system also provides a means of calculating and specifying dose.
• It is important to remember that while an implant may follow the
source distribution rules of a system, it does not comply with the
system unless the method of dose specification and prescription
are also followed.
ICRU 58
ICRU
Two important type of implants in ICRU 58 are,
1. Temporary implant
2. Permanent implant
Temporary Implant
• The radioactive sources are removed from the tissue after the treatment is
completed.
• Radionuclide used have typically longer half life.
Permanent Implant
• The brachytherapy sources remain in the patient, and they will not be removed.
• Radionuclide used have typically shorter half life.
ICRU 58
ICRU 58
Traditionally, the temporary implants were performed
with the linear (like wires) radioactive sources or seeds
arranged in a linear fashion (i.e. ribbons, etc.).
However, in a permanent implants, multiple loose
sources were distributed in random orientations.
With the design of the low energy radioactive
sources in the form of stranded seeds or
radioactive wires, now the permanent implant
can also be performed with linear or
prearranged ribbons.
The loose seed implants are
considered separately in this report.
ICRU 58
For Planning
permanent implants
The number of sources
depends on,
a. Their initial strength.
b. Type of the radioisotope.
For Planning temporary
implants
The total time of implantation
depends on,
a. Number of sources
b. Strengths and source
c. Pattern of distribution of sources
Planning boost permanent and temporary implants,
the number of seeds and the initial activity of the seeds are
adjusted upon the external beam radiation dose.
KERMA (Kinetic Energy
Released in Matter)
The sum of the initial kinetic energie of
all the ionizing charged particles
liberated by uncharged ionizing particles.
K = dEtr/ dm
ABSORBED DOSE
The mean energy imparted by radiation
to a unit
mass of medium
D=dE/dm
1Gy = 1J/Kg
Reference Air Kerma rate
Reference Air Kerma Rate = Air Kerma Rate at a reference point of 1 cm
or 1 m.
OR
It is defined as the air kerma rate measured at one meter
along the perpendicular bisector of the long axis of the
source,corrected for air attenuation and scattering.
Unit : 1 U = μGy/h
The term m^2 is not included inthe unit,since it is inherent
in the definition itself.
Total Reference Air Kerma (TRAK)
TRAK= Σti . Si
Where;
Si = Reference air kerma rate for
each source.
ti = Irradiation time for each source.
Description of Source Patterns
single plane: implant is defined as an implant containing two or more
sources, which lie in the same plane.
two-plane (double-plane): implant contains two planes, which are
generally parallel to each other.
Multi-plane: implant, contains three or more planes.
non-plane: sphere or cylinder.
VOLUMES
(Gross Tumor
volume)
(Clinical
Target Volume)
(Planning
Target Volume)
(Treatment
Volume)
(Irradiated
Volume)
Gross Tumor Volume (GTV)
The palpable or visible/demonstrable extent
and location of the malignant growth.
Clinical Target Volume (CTV)
The volume of the tissue that contains a
gross tumor volume and/or subclinical
microscopic malignant disease which has to
be eliminated.
Planning Target Volume (PTV)
The volume of tissue receiving the
prescribed irradiation.
For an interstitial brachytherapy, the PTV is,
in general, identical to the CTV.
Treatment Volume (TV)
The volume of tissue, which is encompassed
by an isodose surface that has been
specified by the radiation oncologist.
The dose value at this isodose surface is the
minimum target dose
CTV
The maximum diameters measured in three orthogonal directions must be
reported.
CENTRAL PLANE
The plane that is perpendicular to the main
direction of the linear sources and passing
through the estimated center of the implant.
Central Plane (continue)
The plane that is perpendicular to the main
direction of the linear sources and passing
through the estimated center of the implant.
Description of Dose
distribution
Interstitial Brachytherapy
Implants:
1. Non Homogeneous dose
Distribution .
2. High Regions around
Sources.
3. Regions of plateau dose
or local minimum doses.
The dose distribution in a plane perpendicular to linear
and parallel sources, shows a plateau dose region of low
dose gradient. In this example of three sources of 6 cm
long and with 1.5 cm spacing, the dose varies by less than
2% between the sources.
Dose Distribution in One or More Planes
through the Implant
1. The minimum information needed for the dose distribution of
an implant is,
The isodose curves in at least one plane either in tabular form or
by graphical Presentation.
2. The central plane of the implant should be used, If only one
plane is chose.
Prescription Dose
The prescribed dose is defined as the dose, which the physician
intends to give, and enters in the patient’s treatment chart.
Minimum Target Dose (MTD): The minimum dose at the
periphery of the CTV = Minimum dose decided upon by the clinician as
adequate to treat the CTV (minimum peripheral dose).
MTD≅ 90% of the prescribed dose in the Manchsteer system for
interstitial therapy.
Prescription Dose (continue)
Mean Central Dose (MCD) : Dm
The minimum dose at the periphery of the CTV
= Arithmetic mean of the local minimum doses between sources, in the central
planes.
Prescription Dose (continue)
High Dose Volume
The volume of tissue that is encompassed that will receive more than
150% of the mean central dose be reported.
Low Dose Volume
A low dose volume should be defined as a volume within the clinical
target volume, encompassed by an isodose corresponding to 90% of the
prescribed dose. The maximum dimension of the low dose volume in
any plane calculated should be reported.
Prescription Dose (continue)
Dose Uniformity Parameters
ICRU defines the following two methods for the dose uniformity
1. The spread of the individual minimum doses used to calculate the mean
central dose in the central plane (expressed as a percentage of the
mean central dose).
2. The dose homogeneity index; defined as the ratio of minimum
target dose to the mean central dose.
Time Dose Factors
Time and Dose Rates for Temporary Implants
Time = Prescribed dose/initial dose rate
Time Dose Pattern for Temporary Implants
a. Continuous irradiation
b. Non-continuous irradiation
c. Pulsed irradiation
Recommendations for Recording and Reporting
Parameters Required for Recording and Reporting
. Description of Volumes : GTV, PTV,…….
. Description of Sources :
1. Radioisotope and filtration
2. Pattern of source distribution
• Description of Technique and Source pattern
Table 1: Levels of priority for reporting
temporary interstitial implants
Continue
a. Priority
1 . Concerned with doses in the central plan
2 . Required calculations outside the central plan. If this is not
available, then a more detailed description of source pattern under
priority 1 is required.
3 . Additional information mostly of clinical research interest
b. Level of computation
1. No computer needed
2. Hand calculation and/or computer calculation in central plane.
3. 3-D computation needed
c. Essential to establish consistent reporting and related to
past experience, necessary for comparison of brachytherapy data
and for relating outcome to treatment.
Table 3: Levels of priority for reporting implants
with a single stationary source line.
Table 4: Levels of priority for reporting
implants with a moving source.
Table 5: Levels of priority for reporting implants with a
surface applicators
CONCLUSION
 It is very important to follow these
recommendations to achieve the aim of
brachytherapy.
 In this presentation, the ICRU-58
recommended concepts and procedures for dose
specifications and reporting of the interstitial
brachytherapy implants has reviewed.
Selected reference
1. ICRU Report 38: Dose and Volume Specification for Reporting
Intracavitary Gynecology (1985)
2. ICRU Report 58: Dose and Volume Specification for Reporting
Interstitial Therapy (1997)
3. The GEC ESTRO Handbook of Brachytherapy, Editors: Alain
Gerbaulet, Richard Pötter, Jean-Jacques Mazeron, Erik van
Limbergen (2002;107;3225-332
4. ESMP 2013 Reporting in Brachytherapy,Lecture 5 Brachytherapy
Implantation.s
Icru 58.
Icru 58.

More Related Content

What's hot

4dct (2012)
4dct (2012)4dct (2012)
4dct (2012)
Parminder S. Basran
 
Role of SBRT in lung cancer
Role of SBRT in lung cancerRole of SBRT in lung cancer
Role of SBRT in lung cancer
DrAyush Garg
 
Srs and sbrt 2 dr.kiran
Srs and sbrt 2 dr.kiranSrs and sbrt 2 dr.kiran
Srs and sbrt 2 dr.kiran
Kiran Ramakrishna
 
PARTICLE BEAM RADIOTHERAPY
PARTICLE BEAM RADIOTHERAPYPARTICLE BEAM RADIOTHERAPY
PARTICLE BEAM RADIOTHERAPY
Kanhu Charan
 
ICRU 83
ICRU 83ICRU 83
ICRU 83
Subhash Verma
 
Final ICRU 62 ( International commission on radiation units and measurements)
Final ICRU 62 ( International commission on radiation units and measurements)Final ICRU 62 ( International commission on radiation units and measurements)
Final ICRU 62 ( International commission on radiation units and measurements)
DrAyush Garg
 
ICRU 83
ICRU 83ICRU 83
Medulloblatoma - Field Matching In RT Planning - CSI
Medulloblatoma - Field Matching In RT Planning - CSIMedulloblatoma - Field Matching In RT Planning - CSI
Medulloblatoma - Field Matching In RT Planning - CSI
Subhash Thakur
 
Brachytherapy dosimetry systems .R
Brachytherapy dosimetry systems .RBrachytherapy dosimetry systems .R
Brachytherapy dosimetry systems .R
raazvarma
 
Plan evaluation in Radiotherapy- Dr Kiran
Plan evaluation in Radiotherapy- Dr KiranPlan evaluation in Radiotherapy- Dr Kiran
Plan evaluation in Radiotherapy- Dr Kiran
Kiran Ramakrishna
 
Basics And Physics of Brachytherapy
Basics And Physics of BrachytherapyBasics And Physics of Brachytherapy
Basics And Physics of Brachytherapy
Sreekanth Nallam
 
Dose volume histogram
Dose volume histogramDose volume histogram
Dose volume histogram
Sasikumar Sambasivam
 
Treatment plannings i kiran
Treatment plannings i   kiranTreatment plannings i   kiran
Treatment plannings i kiran
Kiran Ramakrishna
 
4D Scan and Respiratory Gating
4D Scan and Respiratory Gating4D Scan and Respiratory Gating
4D Scan and Respiratory Gating
Kothanda Raman
 
Image guided adaptive radiotherapy
Image guided adaptive radiotherapyImage guided adaptive radiotherapy
Image guided adaptive radiotherapy
apollo seminar group
 
Hemi body irradiation
Hemi body irradiationHemi body irradiation
Hemi body irradiation
Nilesh Kucha
 
Concept of bed in radiobiology
Concept of bed in radiobiologyConcept of bed in radiobiology
Concept of bed in radiobiology
RANJITH C P
 
image guided brachytherapy carcinoma cervix
image guided brachytherapy carcinoma cerviximage guided brachytherapy carcinoma cervix
image guided brachytherapy carcinoma cervix
Isha Jaiswal
 
Icru seminar 38
Icru seminar 38Icru seminar 38
Icru seminar 38
masthan basha
 

What's hot (20)

4dct (2012)
4dct (2012)4dct (2012)
4dct (2012)
 
Role of SBRT in lung cancer
Role of SBRT in lung cancerRole of SBRT in lung cancer
Role of SBRT in lung cancer
 
Srs and sbrt 2 dr.kiran
Srs and sbrt 2 dr.kiranSrs and sbrt 2 dr.kiran
Srs and sbrt 2 dr.kiran
 
PARTICLE BEAM RADIOTHERAPY
PARTICLE BEAM RADIOTHERAPYPARTICLE BEAM RADIOTHERAPY
PARTICLE BEAM RADIOTHERAPY
 
ICRU 83
ICRU 83ICRU 83
ICRU 83
 
Final ICRU 62 ( International commission on radiation units and measurements)
Final ICRU 62 ( International commission on radiation units and measurements)Final ICRU 62 ( International commission on radiation units and measurements)
Final ICRU 62 ( International commission on radiation units and measurements)
 
ICRU 83
ICRU 83ICRU 83
ICRU 83
 
Medulloblatoma - Field Matching In RT Planning - CSI
Medulloblatoma - Field Matching In RT Planning - CSIMedulloblatoma - Field Matching In RT Planning - CSI
Medulloblatoma - Field Matching In RT Planning - CSI
 
Brachytherapy dosimetry systems .R
Brachytherapy dosimetry systems .RBrachytherapy dosimetry systems .R
Brachytherapy dosimetry systems .R
 
Plan evaluation in Radiotherapy- Dr Kiran
Plan evaluation in Radiotherapy- Dr KiranPlan evaluation in Radiotherapy- Dr Kiran
Plan evaluation in Radiotherapy- Dr Kiran
 
Basics And Physics of Brachytherapy
Basics And Physics of BrachytherapyBasics And Physics of Brachytherapy
Basics And Physics of Brachytherapy
 
Dose volume histogram
Dose volume histogramDose volume histogram
Dose volume histogram
 
ICRU 38 nayana
ICRU 38 nayanaICRU 38 nayana
ICRU 38 nayana
 
Treatment plannings i kiran
Treatment plannings i   kiranTreatment plannings i   kiran
Treatment plannings i kiran
 
4D Scan and Respiratory Gating
4D Scan and Respiratory Gating4D Scan and Respiratory Gating
4D Scan and Respiratory Gating
 
Image guided adaptive radiotherapy
Image guided adaptive radiotherapyImage guided adaptive radiotherapy
Image guided adaptive radiotherapy
 
Hemi body irradiation
Hemi body irradiationHemi body irradiation
Hemi body irradiation
 
Concept of bed in radiobiology
Concept of bed in radiobiologyConcept of bed in radiobiology
Concept of bed in radiobiology
 
image guided brachytherapy carcinoma cervix
image guided brachytherapy carcinoma cerviximage guided brachytherapy carcinoma cervix
image guided brachytherapy carcinoma cervix
 
Icru seminar 38
Icru seminar 38Icru seminar 38
Icru seminar 38
 

Viewers also liked

Advances in Brachytherapy Treatment Planning and Delivery
Advances in Brachytherapy Treatment Planning and DeliveryAdvances in Brachytherapy Treatment Planning and Delivery
Advances in Brachytherapy Treatment Planning and Delivery
Miami Cancer Institute
 
physics and clinical aspects of interstitial brachytherapy
physics and clinical aspects of interstitial brachytherapyphysics and clinical aspects of interstitial brachytherapy
physics and clinical aspects of interstitial brachytherapyVIMOJ JANARDANAN NAIR
 
Radiotherapy of cervical cancer
Radiotherapy of cervical cancerRadiotherapy of cervical cancer
Radiotherapy of cervical cancerRakshith AVB
 
Radiotherapy in gynaecology
Radiotherapy in gynaecologyRadiotherapy in gynaecology
Radiotherapy in gynaecologydrmcbansal
 
Radiation for Cervix Cancer
Radiation for Cervix CancerRadiation for Cervix Cancer
Radiation for Cervix Cancer
Robert J Miller MD
 
Brachytherapy of gbm
Brachytherapy of gbmBrachytherapy of gbm
Brachytherapy of gbmzahramansouri
 
Brachytherapy med phy-01
Brachytherapy med phy-01Brachytherapy med phy-01
Brachytherapy med phy-01
mtv243
 
Braquiterapia historia
Braquiterapia historiaBraquiterapia historia
Braquiterapia historiapaliza aldo
 
Seed implantation for other body sites
Seed implantation for other body sitesSeed implantation for other body sites
Seed implantation for other body sites
Alfredo Polo
 
2-multichannel yb
 2-multichannel yb 2-multichannel yb
2-multichannel yb
Basalama Ali
 
A Física da Braquiterapia
A Física da BraquiterapiaA Física da Braquiterapia
A Física da Braquiterapia
Lucas Radicchi
 
Brachytherapy permanent seed implant
Brachytherapy permanent seed implantBrachytherapy permanent seed implant
Brachytherapy permanent seed implant
althaf jouhar
 
Management of Carcinoma cervix
Management of Carcinoma cervix Management of Carcinoma cervix
Management of Carcinoma cervix
Drrajan Paliwal
 
Evolution of gynaecological brachytherapy
Evolution of gynaecological brachytherapyEvolution of gynaecological brachytherapy
Evolution of gynaecological brachytherapyRitam Joarder
 
Radiotherapy planning in carcinoma cervix dr rekha
Radiotherapy planning in carcinoma cervix dr rekhaRadiotherapy planning in carcinoma cervix dr rekha
Radiotherapy planning in carcinoma cervix dr rekha
Dr Rekha Arya
 
Conventional Brachytherapy in carcinoma cervix
Conventional Brachytherapy in carcinoma cervixConventional Brachytherapy in carcinoma cervix
Conventional Brachytherapy in carcinoma cervix
Isha Jaiswal
 
Radiation therapy in gynecologic cancer 17-03-15
Radiation therapy in gynecologic cancer 17-03-15Radiation therapy in gynecologic cancer 17-03-15
Radiation therapy in gynecologic cancer 17-03-15
Mahatma Gandhi Medical college & Research Institute - Pondicherry
 
ICRU reports 50 and 62
ICRU reports 50 and 62ICRU reports 50 and 62
ICRU reports 50 and 62
Bharti Devnani
 

Viewers also liked (20)

Advances in Brachytherapy Treatment Planning and Delivery
Advances in Brachytherapy Treatment Planning and DeliveryAdvances in Brachytherapy Treatment Planning and Delivery
Advances in Brachytherapy Treatment Planning and Delivery
 
physics and clinical aspects of interstitial brachytherapy
physics and clinical aspects of interstitial brachytherapyphysics and clinical aspects of interstitial brachytherapy
physics and clinical aspects of interstitial brachytherapy
 
Radiotherapy of cervical cancer
Radiotherapy of cervical cancerRadiotherapy of cervical cancer
Radiotherapy of cervical cancer
 
Radiotherapy in gynaecology
Radiotherapy in gynaecologyRadiotherapy in gynaecology
Radiotherapy in gynaecology
 
Radiation for Cervix Cancer
Radiation for Cervix CancerRadiation for Cervix Cancer
Radiation for Cervix Cancer
 
Brachytherapy Final
Brachytherapy FinalBrachytherapy Final
Brachytherapy Final
 
Brachytherapy of gbm
Brachytherapy of gbmBrachytherapy of gbm
Brachytherapy of gbm
 
Brachytherapy med phy-01
Brachytherapy med phy-01Brachytherapy med phy-01
Brachytherapy med phy-01
 
Braquiterapia historia
Braquiterapia historiaBraquiterapia historia
Braquiterapia historia
 
Seed implantation for other body sites
Seed implantation for other body sitesSeed implantation for other body sites
Seed implantation for other body sites
 
2-multichannel yb
 2-multichannel yb 2-multichannel yb
2-multichannel yb
 
A Física da Braquiterapia
A Física da BraquiterapiaA Física da Braquiterapia
A Física da Braquiterapia
 
Brachytherapy permanent seed implant
Brachytherapy permanent seed implantBrachytherapy permanent seed implant
Brachytherapy permanent seed implant
 
Management of Carcinoma cervix
Management of Carcinoma cervix Management of Carcinoma cervix
Management of Carcinoma cervix
 
D de Jong, Prostate cancer brachytherapy
D de Jong, Prostate cancer brachytherapyD de Jong, Prostate cancer brachytherapy
D de Jong, Prostate cancer brachytherapy
 
Evolution of gynaecological brachytherapy
Evolution of gynaecological brachytherapyEvolution of gynaecological brachytherapy
Evolution of gynaecological brachytherapy
 
Radiotherapy planning in carcinoma cervix dr rekha
Radiotherapy planning in carcinoma cervix dr rekhaRadiotherapy planning in carcinoma cervix dr rekha
Radiotherapy planning in carcinoma cervix dr rekha
 
Conventional Brachytherapy in carcinoma cervix
Conventional Brachytherapy in carcinoma cervixConventional Brachytherapy in carcinoma cervix
Conventional Brachytherapy in carcinoma cervix
 
Radiation therapy in gynecologic cancer 17-03-15
Radiation therapy in gynecologic cancer 17-03-15Radiation therapy in gynecologic cancer 17-03-15
Radiation therapy in gynecologic cancer 17-03-15
 
ICRU reports 50 and 62
ICRU reports 50 and 62ICRU reports 50 and 62
ICRU reports 50 and 62
 

Similar to Icru 58.

Icru 50,62,83 volume deliniation
Icru 50,62,83 volume deliniationIcru 50,62,83 volume deliniation
Icru 50,62,83 volume deliniation
althaf jouhar
 
Icru 29,50 &62
Icru 29,50 &62Icru 29,50 &62
Icru 29,50 &62
Dhiman Das
 
IMRT_Planning_MRM.pdf
IMRT_Planning_MRM.pdfIMRT_Planning_MRM.pdf
IMRT_Planning_MRM.pdf
AsifaAndleeb
 
IMRT by Musaib Mushtaq.ppt
IMRT by Musaib Mushtaq.pptIMRT by Musaib Mushtaq.ppt
IMRT by Musaib Mushtaq.ppt
MusaibMushtaq
 
3 dcrt
3 dcrt3 dcrt
TARGET VOLUMES IN RADIATION ONCOLOGY.pptx
TARGET VOLUMES IN RADIATION ONCOLOGY.pptxTARGET VOLUMES IN RADIATION ONCOLOGY.pptx
TARGET VOLUMES IN RADIATION ONCOLOGY.pptx
AshishNigam63
 
Imrt&vmat
Imrt&vmatImrt&vmat
Imrt&vmat
HEBAGOMAA1984
 
ICRU REPORT 50 and 62.pptx
ICRU REPORT 50 and 62.pptxICRU REPORT 50 and 62.pptx
ICRU REPORT 50 and 62.pptx
ssuser694481
 
Systems of Brachy.ppt
Systems of Brachy.pptSystems of Brachy.ppt
Systems of Brachy.ppt
Sheedh4
 
Radiotherapy contouring guideline for non-hodgkin lymphoma
Radiotherapy contouring guideline for non-hodgkin lymphomaRadiotherapy contouring guideline for non-hodgkin lymphoma
Radiotherapy contouring guideline for non-hodgkin lymphoma
ketan kalariya
 
The Alphabet Soup Of Radiotherapy
The Alphabet Soup Of RadiotherapyThe Alphabet Soup Of Radiotherapy
The Alphabet Soup Of Radiotherapyfondas vakalis
 
Patient data acquisition and treatment verification.pptx
Patient data acquisition and treatment verification.pptxPatient data acquisition and treatment verification.pptx
Patient data acquisition and treatment verification.pptx
Juliyet K Joy
 
Total body irradiation
Total body irradiationTotal body irradiation
Total body irradiation
Bharat Mistary
 
Lung sbrt ppt
Lung  sbrt pptLung  sbrt ppt
Lung sbrt ppt
Dr. Rituparna Biswas
 
Comparative dosimetry of forward and inverse treatment planning for Intensity...
Comparative dosimetry of forward and inverse treatment planning for Intensity...Comparative dosimetry of forward and inverse treatment planning for Intensity...
Comparative dosimetry of forward and inverse treatment planning for Intensity...
iosrjce
 
New Techniques in Radiotherapy
New Techniques in RadiotherapyNew Techniques in Radiotherapy
New Techniques in Radiotherapy
Santam Chakraborty
 
IMRT and 3D CRT in cervical Cancers
IMRT and 3D CRT in cervical CancersIMRT and 3D CRT in cervical Cancers
IMRT and 3D CRT in cervical Cancers
Santam Chakraborty
 
Head and neck; brachytherapy.pptx final
Head and neck;  brachytherapy.pptx finalHead and neck;  brachytherapy.pptx final
Head and neck; brachytherapy.pptx final
pgclubrcc
 
Icru 50
Icru 50Icru 50

Similar to Icru 58. (20)

Icru 50,62,83 volume deliniation
Icru 50,62,83 volume deliniationIcru 50,62,83 volume deliniation
Icru 50,62,83 volume deliniation
 
Icru 29,50 &62
Icru 29,50 &62Icru 29,50 &62
Icru 29,50 &62
 
IMRT_Planning_MRM.pdf
IMRT_Planning_MRM.pdfIMRT_Planning_MRM.pdf
IMRT_Planning_MRM.pdf
 
IMRT by Musaib Mushtaq.ppt
IMRT by Musaib Mushtaq.pptIMRT by Musaib Mushtaq.ppt
IMRT by Musaib Mushtaq.ppt
 
3 dcrt
3 dcrt3 dcrt
3 dcrt
 
TARGET VOLUMES IN RADIATION ONCOLOGY.pptx
TARGET VOLUMES IN RADIATION ONCOLOGY.pptxTARGET VOLUMES IN RADIATION ONCOLOGY.pptx
TARGET VOLUMES IN RADIATION ONCOLOGY.pptx
 
Imrt&vmat
Imrt&vmatImrt&vmat
Imrt&vmat
 
ICRU REPORT 50 and 62.pptx
ICRU REPORT 50 and 62.pptxICRU REPORT 50 and 62.pptx
ICRU REPORT 50 and 62.pptx
 
Systems of Brachy.ppt
Systems of Brachy.pptSystems of Brachy.ppt
Systems of Brachy.ppt
 
Radiotherapy contouring guideline for non-hodgkin lymphoma
Radiotherapy contouring guideline for non-hodgkin lymphomaRadiotherapy contouring guideline for non-hodgkin lymphoma
Radiotherapy contouring guideline for non-hodgkin lymphoma
 
Iort
IortIort
Iort
 
The Alphabet Soup Of Radiotherapy
The Alphabet Soup Of RadiotherapyThe Alphabet Soup Of Radiotherapy
The Alphabet Soup Of Radiotherapy
 
Patient data acquisition and treatment verification.pptx
Patient data acquisition and treatment verification.pptxPatient data acquisition and treatment verification.pptx
Patient data acquisition and treatment verification.pptx
 
Total body irradiation
Total body irradiationTotal body irradiation
Total body irradiation
 
Lung sbrt ppt
Lung  sbrt pptLung  sbrt ppt
Lung sbrt ppt
 
Comparative dosimetry of forward and inverse treatment planning for Intensity...
Comparative dosimetry of forward and inverse treatment planning for Intensity...Comparative dosimetry of forward and inverse treatment planning for Intensity...
Comparative dosimetry of forward and inverse treatment planning for Intensity...
 
New Techniques in Radiotherapy
New Techniques in RadiotherapyNew Techniques in Radiotherapy
New Techniques in Radiotherapy
 
IMRT and 3D CRT in cervical Cancers
IMRT and 3D CRT in cervical CancersIMRT and 3D CRT in cervical Cancers
IMRT and 3D CRT in cervical Cancers
 
Head and neck; brachytherapy.pptx final
Head and neck;  brachytherapy.pptx finalHead and neck;  brachytherapy.pptx final
Head and neck; brachytherapy.pptx final
 
Icru 50
Icru 50Icru 50
Icru 50
 

Recently uploaded

Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
EverAndrsGuerraGuerr
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
Nguyen Thanh Tu Collection
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
MIRIAMSALINAS13
 
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Po-Chuan Chen
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
EduSkills OECD
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
Vikramjit Singh
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
Levi Shapiro
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
Peter Windle
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
kaushalkr1407
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
SACHIN R KONDAGURI
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
Tamralipta Mahavidyalaya
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 

Recently uploaded (20)

Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
 
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 

Icru 58.

  • 2. INTRODUCTION With the introduction of miniaturized brachytherapy sources, the sophisticated 3-D source localization methods have been introduced, which can be linked to computerized methods for dose calculation. Therefore, a common language is valuable to provide a method of dose specification and reporting which can be used for implants of all types of interstitial brachytherapy procedures.
  • 3. 1985: ICRU Report 38, Was written regarding the Dose and volume specification as well as reporting intracavitary Brachytherapy in GYN. 1997: ICRU Report 58, Was written to generate a guideline about the dose and volumes specification for reporting interstitial Brachytherapy.
  • 4. ICRU 58 Aim: to develop a common language based on existing Concepts. 1. usable to describe what has been done. 2. closely related to the outcome of the treatment. 3. generally understood. Consistency with external beam radiotherapy (EBT) definition of volumes – the same. ICRU reference point for dosimetry in EBT – cannot be taken over directly for interstitial BT.
  • 5. ICRU 58 There are several historic systems of prescribing brachytherapy • –Manchester system • –Paris system • Quimby system
  • 6. • The term “system” denotes a set of rules which takes into account the source types , strengths, geometry and method of application to obtain suitable dose distributions over the volume(s) to be treated. The system also provides a means of calculating and specifying dose. • It is important to remember that while an implant may follow the source distribution rules of a system, it does not comply with the system unless the method of dose specification and prescription are also followed. ICRU 58
  • 7. ICRU Two important type of implants in ICRU 58 are, 1. Temporary implant 2. Permanent implant
  • 8. Temporary Implant • The radioactive sources are removed from the tissue after the treatment is completed. • Radionuclide used have typically longer half life. Permanent Implant • The brachytherapy sources remain in the patient, and they will not be removed. • Radionuclide used have typically shorter half life. ICRU 58
  • 9. ICRU 58 Traditionally, the temporary implants were performed with the linear (like wires) radioactive sources or seeds arranged in a linear fashion (i.e. ribbons, etc.). However, in a permanent implants, multiple loose sources were distributed in random orientations.
  • 10. With the design of the low energy radioactive sources in the form of stranded seeds or radioactive wires, now the permanent implant can also be performed with linear or prearranged ribbons. The loose seed implants are considered separately in this report. ICRU 58
  • 11. For Planning permanent implants The number of sources depends on, a. Their initial strength. b. Type of the radioisotope. For Planning temporary implants The total time of implantation depends on, a. Number of sources b. Strengths and source c. Pattern of distribution of sources
  • 12. Planning boost permanent and temporary implants, the number of seeds and the initial activity of the seeds are adjusted upon the external beam radiation dose.
  • 13. KERMA (Kinetic Energy Released in Matter) The sum of the initial kinetic energie of all the ionizing charged particles liberated by uncharged ionizing particles. K = dEtr/ dm ABSORBED DOSE The mean energy imparted by radiation to a unit mass of medium D=dE/dm 1Gy = 1J/Kg
  • 14. Reference Air Kerma rate Reference Air Kerma Rate = Air Kerma Rate at a reference point of 1 cm or 1 m. OR It is defined as the air kerma rate measured at one meter along the perpendicular bisector of the long axis of the source,corrected for air attenuation and scattering. Unit : 1 U = μGy/h The term m^2 is not included inthe unit,since it is inherent in the definition itself.
  • 15. Total Reference Air Kerma (TRAK) TRAK= Σti . Si Where; Si = Reference air kerma rate for each source. ti = Irradiation time for each source.
  • 16. Description of Source Patterns single plane: implant is defined as an implant containing two or more sources, which lie in the same plane. two-plane (double-plane): implant contains two planes, which are generally parallel to each other. Multi-plane: implant, contains three or more planes. non-plane: sphere or cylinder.
  • 17. VOLUMES (Gross Tumor volume) (Clinical Target Volume) (Planning Target Volume) (Treatment Volume) (Irradiated Volume)
  • 18. Gross Tumor Volume (GTV) The palpable or visible/demonstrable extent and location of the malignant growth. Clinical Target Volume (CTV) The volume of the tissue that contains a gross tumor volume and/or subclinical microscopic malignant disease which has to be eliminated.
  • 19. Planning Target Volume (PTV) The volume of tissue receiving the prescribed irradiation. For an interstitial brachytherapy, the PTV is, in general, identical to the CTV. Treatment Volume (TV) The volume of tissue, which is encompassed by an isodose surface that has been specified by the radiation oncologist. The dose value at this isodose surface is the minimum target dose
  • 20. CTV The maximum diameters measured in three orthogonal directions must be reported.
  • 21. CENTRAL PLANE The plane that is perpendicular to the main direction of the linear sources and passing through the estimated center of the implant.
  • 22. Central Plane (continue) The plane that is perpendicular to the main direction of the linear sources and passing through the estimated center of the implant.
  • 23. Description of Dose distribution Interstitial Brachytherapy Implants: 1. Non Homogeneous dose Distribution . 2. High Regions around Sources. 3. Regions of plateau dose or local minimum doses. The dose distribution in a plane perpendicular to linear and parallel sources, shows a plateau dose region of low dose gradient. In this example of three sources of 6 cm long and with 1.5 cm spacing, the dose varies by less than 2% between the sources.
  • 24. Dose Distribution in One or More Planes through the Implant 1. The minimum information needed for the dose distribution of an implant is, The isodose curves in at least one plane either in tabular form or by graphical Presentation. 2. The central plane of the implant should be used, If only one plane is chose.
  • 25. Prescription Dose The prescribed dose is defined as the dose, which the physician intends to give, and enters in the patient’s treatment chart. Minimum Target Dose (MTD): The minimum dose at the periphery of the CTV = Minimum dose decided upon by the clinician as adequate to treat the CTV (minimum peripheral dose). MTD≅ 90% of the prescribed dose in the Manchsteer system for interstitial therapy.
  • 26. Prescription Dose (continue) Mean Central Dose (MCD) : Dm The minimum dose at the periphery of the CTV = Arithmetic mean of the local minimum doses between sources, in the central planes.
  • 27. Prescription Dose (continue) High Dose Volume The volume of tissue that is encompassed that will receive more than 150% of the mean central dose be reported. Low Dose Volume A low dose volume should be defined as a volume within the clinical target volume, encompassed by an isodose corresponding to 90% of the prescribed dose. The maximum dimension of the low dose volume in any plane calculated should be reported.
  • 28. Prescription Dose (continue) Dose Uniformity Parameters ICRU defines the following two methods for the dose uniformity 1. The spread of the individual minimum doses used to calculate the mean central dose in the central plane (expressed as a percentage of the mean central dose). 2. The dose homogeneity index; defined as the ratio of minimum target dose to the mean central dose.
  • 29. Time Dose Factors Time and Dose Rates for Temporary Implants Time = Prescribed dose/initial dose rate Time Dose Pattern for Temporary Implants a. Continuous irradiation b. Non-continuous irradiation c. Pulsed irradiation
  • 30. Recommendations for Recording and Reporting Parameters Required for Recording and Reporting . Description of Volumes : GTV, PTV,……. . Description of Sources : 1. Radioisotope and filtration 2. Pattern of source distribution • Description of Technique and Source pattern
  • 31. Table 1: Levels of priority for reporting temporary interstitial implants
  • 33. a. Priority 1 . Concerned with doses in the central plan 2 . Required calculations outside the central plan. If this is not available, then a more detailed description of source pattern under priority 1 is required. 3 . Additional information mostly of clinical research interest b. Level of computation 1. No computer needed 2. Hand calculation and/or computer calculation in central plane. 3. 3-D computation needed c. Essential to establish consistent reporting and related to past experience, necessary for comparison of brachytherapy data and for relating outcome to treatment.
  • 34. Table 3: Levels of priority for reporting implants with a single stationary source line.
  • 35. Table 4: Levels of priority for reporting implants with a moving source.
  • 36. Table 5: Levels of priority for reporting implants with a surface applicators
  • 37. CONCLUSION  It is very important to follow these recommendations to achieve the aim of brachytherapy.  In this presentation, the ICRU-58 recommended concepts and procedures for dose specifications and reporting of the interstitial brachytherapy implants has reviewed.
  • 38. Selected reference 1. ICRU Report 38: Dose and Volume Specification for Reporting Intracavitary Gynecology (1985) 2. ICRU Report 58: Dose and Volume Specification for Reporting Interstitial Therapy (1997) 3. The GEC ESTRO Handbook of Brachytherapy, Editors: Alain Gerbaulet, Richard Pötter, Jean-Jacques Mazeron, Erik van Limbergen (2002;107;3225-332 4. ESMP 2013 Reporting in Brachytherapy,Lecture 5 Brachytherapy Implantation.s